These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 36345412)

  • 21. A rapid RNA extraction-free lateral flow assay for molecular point-of-care detection of SARS-CoV-2 augmented by chemical probes.
    Dighe K; Moitra P; Alafeef M; Gunaseelan N; Pan D
    Biosens Bioelectron; 2022 Mar; 200():113900. PubMed ID: 34959185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Point-of-Care Diagnostics of COVID-19: From Current Work to Future Perspectives.
    Hussein HA; Hassan RYA; Chino M; Febbraio F
    Sensors (Basel); 2020 Jul; 20(15):. PubMed ID: 32752043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Utility of Biosensing Platforms for Confirmation of SARS-CoV-2 Infection.
    Phan LMT; Tieu MV; Pham TT; Cho S
    Biosensors (Basel); 2021 May; 11(6):. PubMed ID: 34073756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical utility of novel biosensing platform: Diagnosis of coronavirus SARS-CoV-2 at point of care.
    Aljabali AAA; Pal K; Serrano-Aroca A; Takayama K; Dua K; Tambuwala MM
    Mater Lett; 2021 Dec; 304():130612. PubMed ID: 34381287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emerging point-of-care biosensors for rapid diagnosis of COVID-19: current progress, challenges, and future prospects.
    Rasmi Y; Li X; Khan J; Ozer T; Choi JR
    Anal Bioanal Chem; 2021 Jul; 413(16):4137-4159. PubMed ID: 34008124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of the surface ligand on the performance of electrochemical SARS-CoV-2 antigen biosensors.
    Szunerits S; Pagneux Q; Swaidan A; Mishyn V; Roussel A; Cambillau C; Devos D; Engelmann I; Alidjinou EK; Happy H; Boukherroub R
    Anal Bioanal Chem; 2022 Jan; 414(1):103-113. PubMed ID: 33616686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Scalable COVID-19 Detection Enabled by Lab-on-Chip Biosensors.
    Tymm C; Zhou J; Tadimety A; Burklund A; Zhang JXJ
    Cell Mol Bioeng; 2020 Aug; 13(4):313-329. PubMed ID: 32837587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Update on Molecular Diagnostics for COVID-19.
    Islam KU; Iqbal J
    Front Cell Infect Microbiol; 2020; 10():560616. PubMed ID: 33244462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving "lab-on-a-chip" techniques using biomedical nanotechnology: a review.
    Gorjikhah F; Davaran S; Salehi R; Bakhtiari M; Hasanzadeh A; Panahi Y; Emamverdy M; Akbarzadeh A
    Artif Cells Nanomed Biotechnol; 2016 Nov; 44(7):1609-14. PubMed ID: 26758969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinically practiced and commercially viable nanobio engineered analytical methods for COVID-19 diagnosis.
    Mahapatra S; Chandra P
    Biosens Bioelectron; 2020 Oct; 165():112361. PubMed ID: 32729494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness and use of reverse transcriptase polymerase chain reaction point of care testing in a large-scale COVID-19 surveillance system.
    Mack CD; Wasserman EB; Hostler CJ; Solomon G; Anderson DJ; Walton P; Hawaldar K; Myers E; Best M; Eichner D; Mayer T; Sills A
    Pharmacoepidemiol Drug Saf; 2022 May; 31(5):511-518. PubMed ID: 35225407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Point-of-Care PCR Assays for COVID-19 Detection.
    Gupta N; Augustine S; Narayan T; O'Riordan A; Das A; Kumar D; Luong JHT; Malhotra BD
    Biosensors (Basel); 2021 May; 11(5):. PubMed ID: 34062874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Point-of-care cancer diagnostic devices: From academic research to clinical translation.
    Syedmoradi L; Norton ML; Omidfar K
    Talanta; 2021 Apr; 225():122002. PubMed ID: 33592810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of point-of-care nanobiosensors for breast cancers diagnosis.
    Sharifi M; Hasan A; Attar F; Taghizadeh A; Falahati M
    Talanta; 2020 Sep; 217():121091. PubMed ID: 32498898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanomaterials-based sensors for the detection of COVID-19: A review.
    Naikoo GA; Arshad F; Hassan IU; Awan T; Salim H; Pedram MZ; Ahmed W; Patel V; Karakoti AS; Vinu A
    Bioeng Transl Med; 2022 Sep; 7(3):e10305. PubMed ID: 35599642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advancements in Detection Approaches of Severe Acute Respiratory Syndrome Coronavirus 2.
    Hossain MAM; Uddin SMK; Hashem A; Mamun MA; Sagadevan S; Johan MR
    Malays J Med Sci; 2022 Dec; 29(6):15-33. PubMed ID: 36818907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microneedle-based devices for point-of-care infectious disease diagnostics.
    Dixon RV; Skaria E; Lau WM; Manning P; Birch-Machin MA; Moghimi SM; Ng KW
    Acta Pharm Sin B; 2021 Aug; 11(8):2344-2361. PubMed ID: 34150486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent Progress in Nanotechnology for COVID-19 Prevention, Diagnostics and Treatment.
    Rasmi Y; Saloua KS; Nemati M; Choi JR
    Nanomaterials (Basel); 2021 Jul; 11(7):. PubMed ID: 34361174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrochemical SARS-CoV-2 Sensing at Point-of-Care and Artificial Intelligence for Intelligent COVID-19 Management.
    Kaushik AK; Dhau JS; Gohel H; Mishra YK; Kateb B; Kim NY; Goswami DY
    ACS Appl Bio Mater; 2020 Nov; 3(11):7306-7325. PubMed ID: 35019473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.